ArticleNature communications2026
scMEDAL: interpretable single-cell transcriptomics analysis with batch effect visualization via deep mixed-effects autoencoder.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Critical Synthesis of Machine Learning in Autism Spectrum Disorder Genomic Research: From Transcriptomics to Microbiome.Medeniyet medical journal · 2026Article
- scMEDAL: interpretable single-cell transcriptomics analysis with batch effect visualization via deep mixed-effects autoencoder.Nature communications · 2026Article
Corrections and comments
- Update of
- Update of
Authors and funding
4 authors.
Funding
Abstract
Single-cell RNA sequencing enables high-resolution analysis of cellular heterogeneity, yet disentangling biological signal from batch effects remains challenging. Existing batch-correction algorithms suppress or discard batch-related variation rather than modeling it. We propose scMEDAL-single-cell Mixed Effects Deep Autoencoder Learning-a framework that separately and independently models batch-invariant and batch-specific effects. The principal innovation, scMEDAL-RE, is a random-effects Bayesian autoencoder that learns batch-specific representations while preserving biologically meaningful information confounded with batch effects, signal often lost under standard correction. Across diverse conditions (autism, leukemia, cardiovascular), cell types, and technical and biological effects, scMEDAL-RE produces interpretable, batch-specific embeddings that complement multiple batch correction methods, improving prediction of disease status, donor group, and tissue. scMEDAL also provides generative visualizations-including counterfactual reconstructions of a cell's expression as if acquired in another batch. Overall, scMEDAL is a versatile, interpretable framework that complements existing correction, providing insight into cellular heterogeneity and data acquisition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.